Status of endothelial dependent vasodilation in patients with hyperuricemia

Masahiko Kato, Ichiro Hisatome, Yoko Tomikura, Kazuhiko Kotani, Toru Kinugawa, Kazuhide Ogino, Katsunori Ishida, Osamu Igawa, Chiaki Shigemasa, Virend Somers

Research output: Contribution to journalArticle

102 Citations (Scopus)

Abstract

Hyperuricemia has been associated with an increased risk for cardiovascular disease and increased mortality. However, the biologic mechanisms that link elevated serum uric acid to cardiovascular disease are uncertain. This study tested the hypothesis that elevated serum uric acid is associated with impaired endothelial function in hyperuricemic patients without any overt cardiovascular disease. Seventeen male patients with hyperuricemia (mean age 42 ± 4 years) and 9 control subjects (mean age 45 ± 5 years) were studied. All subjects were nonsmokers. All patients had never been treated for hyperuricemia, were on no medications, and were free of any other known diseases. Endothelial function was evaluated by flow-mediated dilation measured by ultrasound. Flow-mediated dilation was significantly impaired in patients with hyperuricemia (4.0 ± 0.7%) compared with control subjects (6.4 ± 0.8%) (p = 0.044). Flow-mediated dilation correlated inversely with uric acid levels (r = -0.4, p = 0.05). Nitrate-induced dilation was 12.3 ± 1.0% in patients with hyperuricemia and 11.8 ± 2.3% in control subjects (p = 0.82). Impaired endothelial-dependent vasodilation is present in hyperuricemic patients even in the absence of any overt cardiovascular disease. The elevated serum uric acid, per se, may constitute a novel risk factor for endothelial dysfunction.

Original languageEnglish (US)
Pages (from-to)1576-1578
Number of pages3
JournalAmerican Journal of Cardiology
Volume96
Issue number11
DOIs
StatePublished - Dec 1 2005

Fingerprint

Hyperuricemia
Vasodilation
Uric Acid
Dilatation
Cardiovascular Diseases
Serum
Nitrates
Mortality

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Status of endothelial dependent vasodilation in patients with hyperuricemia. / Kato, Masahiko; Hisatome, Ichiro; Tomikura, Yoko; Kotani, Kazuhiko; Kinugawa, Toru; Ogino, Kazuhide; Ishida, Katsunori; Igawa, Osamu; Shigemasa, Chiaki; Somers, Virend.

In: American Journal of Cardiology, Vol. 96, No. 11, 01.12.2005, p. 1576-1578.

Research output: Contribution to journalArticle

Kato, M, Hisatome, I, Tomikura, Y, Kotani, K, Kinugawa, T, Ogino, K, Ishida, K, Igawa, O, Shigemasa, C & Somers, V 2005, 'Status of endothelial dependent vasodilation in patients with hyperuricemia', American Journal of Cardiology, vol. 96, no. 11, pp. 1576-1578. https://doi.org/10.1016/j.amjcard.2005.07.068
Kato M, Hisatome I, Tomikura Y, Kotani K, Kinugawa T, Ogino K et al. Status of endothelial dependent vasodilation in patients with hyperuricemia. American Journal of Cardiology. 2005 Dec 1;96(11):1576-1578. https://doi.org/10.1016/j.amjcard.2005.07.068
Kato, Masahiko ; Hisatome, Ichiro ; Tomikura, Yoko ; Kotani, Kazuhiko ; Kinugawa, Toru ; Ogino, Kazuhide ; Ishida, Katsunori ; Igawa, Osamu ; Shigemasa, Chiaki ; Somers, Virend. / Status of endothelial dependent vasodilation in patients with hyperuricemia. In: American Journal of Cardiology. 2005 ; Vol. 96, No. 11. pp. 1576-1578.
@article{0b838cbc8d6b4ed28cef7f44e4192593,
title = "Status of endothelial dependent vasodilation in patients with hyperuricemia",
abstract = "Hyperuricemia has been associated with an increased risk for cardiovascular disease and increased mortality. However, the biologic mechanisms that link elevated serum uric acid to cardiovascular disease are uncertain. This study tested the hypothesis that elevated serum uric acid is associated with impaired endothelial function in hyperuricemic patients without any overt cardiovascular disease. Seventeen male patients with hyperuricemia (mean age 42 ± 4 years) and 9 control subjects (mean age 45 ± 5 years) were studied. All subjects were nonsmokers. All patients had never been treated for hyperuricemia, were on no medications, and were free of any other known diseases. Endothelial function was evaluated by flow-mediated dilation measured by ultrasound. Flow-mediated dilation was significantly impaired in patients with hyperuricemia (4.0 ± 0.7{\%}) compared with control subjects (6.4 ± 0.8{\%}) (p = 0.044). Flow-mediated dilation correlated inversely with uric acid levels (r = -0.4, p = 0.05). Nitrate-induced dilation was 12.3 ± 1.0{\%} in patients with hyperuricemia and 11.8 ± 2.3{\%} in control subjects (p = 0.82). Impaired endothelial-dependent vasodilation is present in hyperuricemic patients even in the absence of any overt cardiovascular disease. The elevated serum uric acid, per se, may constitute a novel risk factor for endothelial dysfunction.",
author = "Masahiko Kato and Ichiro Hisatome and Yoko Tomikura and Kazuhiko Kotani and Toru Kinugawa and Kazuhide Ogino and Katsunori Ishida and Osamu Igawa and Chiaki Shigemasa and Virend Somers",
year = "2005",
month = "12",
day = "1",
doi = "10.1016/j.amjcard.2005.07.068",
language = "English (US)",
volume = "96",
pages = "1576--1578",
journal = "American Journal of Cardiology",
issn = "0002-9149",
publisher = "Elsevier Inc.",
number = "11",

}

TY - JOUR

T1 - Status of endothelial dependent vasodilation in patients with hyperuricemia

AU - Kato, Masahiko

AU - Hisatome, Ichiro

AU - Tomikura, Yoko

AU - Kotani, Kazuhiko

AU - Kinugawa, Toru

AU - Ogino, Kazuhide

AU - Ishida, Katsunori

AU - Igawa, Osamu

AU - Shigemasa, Chiaki

AU - Somers, Virend

PY - 2005/12/1

Y1 - 2005/12/1

N2 - Hyperuricemia has been associated with an increased risk for cardiovascular disease and increased mortality. However, the biologic mechanisms that link elevated serum uric acid to cardiovascular disease are uncertain. This study tested the hypothesis that elevated serum uric acid is associated with impaired endothelial function in hyperuricemic patients without any overt cardiovascular disease. Seventeen male patients with hyperuricemia (mean age 42 ± 4 years) and 9 control subjects (mean age 45 ± 5 years) were studied. All subjects were nonsmokers. All patients had never been treated for hyperuricemia, were on no medications, and were free of any other known diseases. Endothelial function was evaluated by flow-mediated dilation measured by ultrasound. Flow-mediated dilation was significantly impaired in patients with hyperuricemia (4.0 ± 0.7%) compared with control subjects (6.4 ± 0.8%) (p = 0.044). Flow-mediated dilation correlated inversely with uric acid levels (r = -0.4, p = 0.05). Nitrate-induced dilation was 12.3 ± 1.0% in patients with hyperuricemia and 11.8 ± 2.3% in control subjects (p = 0.82). Impaired endothelial-dependent vasodilation is present in hyperuricemic patients even in the absence of any overt cardiovascular disease. The elevated serum uric acid, per se, may constitute a novel risk factor for endothelial dysfunction.

AB - Hyperuricemia has been associated with an increased risk for cardiovascular disease and increased mortality. However, the biologic mechanisms that link elevated serum uric acid to cardiovascular disease are uncertain. This study tested the hypothesis that elevated serum uric acid is associated with impaired endothelial function in hyperuricemic patients without any overt cardiovascular disease. Seventeen male patients with hyperuricemia (mean age 42 ± 4 years) and 9 control subjects (mean age 45 ± 5 years) were studied. All subjects were nonsmokers. All patients had never been treated for hyperuricemia, were on no medications, and were free of any other known diseases. Endothelial function was evaluated by flow-mediated dilation measured by ultrasound. Flow-mediated dilation was significantly impaired in patients with hyperuricemia (4.0 ± 0.7%) compared with control subjects (6.4 ± 0.8%) (p = 0.044). Flow-mediated dilation correlated inversely with uric acid levels (r = -0.4, p = 0.05). Nitrate-induced dilation was 12.3 ± 1.0% in patients with hyperuricemia and 11.8 ± 2.3% in control subjects (p = 0.82). Impaired endothelial-dependent vasodilation is present in hyperuricemic patients even in the absence of any overt cardiovascular disease. The elevated serum uric acid, per se, may constitute a novel risk factor for endothelial dysfunction.

UR - http://www.scopus.com/inward/record.url?scp=28044470533&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=28044470533&partnerID=8YFLogxK

U2 - 10.1016/j.amjcard.2005.07.068

DO - 10.1016/j.amjcard.2005.07.068

M3 - Article

VL - 96

SP - 1576

EP - 1578

JO - American Journal of Cardiology

JF - American Journal of Cardiology

SN - 0002-9149

IS - 11

ER -